News: Is less radiation after lumpectomy feasible?

Article

Less radiation after lumpectomy for women with early breast cancer is feasible.

It would seem so in women with early breast cancer, according to the results of two large trials, but United States and European researchers are still skeptical about the long-term adverse effects.

Findings from the first trial, the Standardization of Breast Radiotherapy Trial, which followed 2,000 lumpectomy patients for 5 years, suggest that the total amount of radiation can be safely reduced by about 10 Gy (from the usual 50 Gy) and delivered in fewer sessions
(13 instead of 25) over a 5-week period, an approach known as hypofractionation, with no greater rates of local recurrence or adverse effects.

The second trial performed in Canada, which followed 1,000 women for 10 years and which compared a 3-week schedule of 42.5 Gy in 16 fractions against standard treatment, also found no statistically significant difference between the groups in terms of local recurrence or adverse effects.

McNeil C. Less radiation after lumpectomy in breast cancer: new results stir debate. J Natl Cancer Inst. 2008;100:910-911.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.